[ad_1] COPENHAGEN (Reuters) – Denmark, Europe’s largest exporter of mink pelts, said it will cull millions of the animals bred for their fur after COVID-19 infections were transmitted to their…
Tag: Biotechnology & Medical Research (TRBC level 4)
S.Korea shares close at record high on chip, auto boost
[ad_1] * KOSPI hits record closing high, foreigners net buyers * KRW ends at strongest close since June 2018 vs USD * South Korea benchmark bond yield rises * For…
Link between COVID-19 shot, Swiss death ‘highly unlikely’ – drugs regulator
[ad_1] ZURICH (Reuters) – Swiss drugs regulator swissmedic on Wednesday said it saw no link between the death of a 91-year old person in the canton of Lucerne and the…
Roche says faricimab meets goals in trial against rivals’ Eylea
[ad_1] FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann ZURICH (Reuters) – Swiss drugmaker Roche said on…
Roche, Sanofi arthritis drugs reduce death rates among sickest COVID-19 patients
[ad_1] LONDON (Reuters) – Treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive…
Take AstraZeneca’s ‘fantastic’ vaccine, Germany tells sceptical public
[ad_1] BERLIN (Reuters) – Germany’s government and health chiefs on Friday urged the public to take AstraZeneca’s coronavirus vaccine, seeking to stem a tide of scepticism about its effectiveness and…
Instant view: Pfizer, BioNTech say their COVID-19 vaccine is more than 90% effective
[ad_1] (Reuters) – Pfizer Inc PFE.N said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major…
UK to roll out Astra/Oxford COVID vaccine after world-first approval
[ad_1] By Alistair Smout, Paul Sandle LONDON (Reuters) – Britain on Wednesday became the first country to approve the coronavirus vaccine developed by Oxford University and AstraZeneca, hoping that rapid…
Lonza shortlists Lanxess, private equity in unit sale, sources say
[ad_1] FRANKFURT (Reuters) – Swiss contract drug maker Lonza has shortlisted German chemicals group Lanxess and private equity groups in the sale of its Lonza Specialty Ingredients (LSI) unit worth…